No definition available.
Fetus and newborn affected by other complications of labour and delivery
P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
83 |
4. Check minimum number of eventsNone |
83 |
5. Include endpointsNone |
83 |
6. Filter based on genotype QC (FinnGen only) |
83 |
Control definitions (FinnGen only)
- Control exclude
- P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[0-4]
- Name in latin
- Fetus et neonatus aliis complicationibus laborum et partus affectus
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by other complications of labour and delivery
based on the number of shared cases.
Similar with more cases:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12078 | 5291 | 6784 |
| Only index persons | 3261 | 1433 | 1828 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.15 | 0.19 |
| Only index persons | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 0.01 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 83 | 51 | 32 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 76
- Matched controls
- 761
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
+∞
45.4
39
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
24.7
16.4
23
13
P03.3
ICD-10 Finland
Fetus and newborn affected by delivery by vacuum extractor [ventouse]
+∞
12.9
12
*
P03.0
ICD-10 Finland
Fetus and newborn affected by breech delivery and extraction
+∞
12.9
12
*
P03.1
ICD-10 Finland
Fetus and newborn affected by other malpresentation, malposition and disproportion during labour and delivery
+∞
9.6
9
*
P07.3
ICD-10 Finland
Other preterm infants
13.2
9.3
16
15
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
+∞
8.5
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1616796) Gas panel - Central venous blood
6
9
7.06
2.91
6.8
3.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
11
37
3.27
2.80
4.5
7.2
%
0.2
0.0
—
5
15
(3017181) Myelocytes/100 leukocytes in Blood
11
39
3.09
2.58
4.5
7.1
%
2.0
0.2
—
5
17
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
18
4.13
2.30
1.4
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
32
3.02
2.06
2.3
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
16
3.95
1.97
1.3
2.1
—
—
—
0
0
(3019225) pH of Specimen
7
23
3.22
1.84
19.1
4.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
22
2.85
1.46
1.5
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
16
3.25
1.45
7.2
16.7
%
49.8
58.4
—
5
16
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
138
1.80
1.44
2.4
3.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
70
2.01
1.32
1.8
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
19
119
1.77
1.24
3.5
5.1
inr
1.1
1.1
—
8
40
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
36
0.00
1.17
0.0
3.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
20
2.59
1.16
2.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
167
1.61
1.07
2.6
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
21
142
1.64
1.05
4.0
5.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
28
0.00
1.00
0.0
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
28
0.00
1.00
0.0
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
41
329
1.48
0.95
5.3
7.0
mmol/l
5.7
5.9
0.24
35
294
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
23
307
0.65
0.94
1.9
1.8
u/ml
0.4
3.4
—
6
62
(3013512) EKG study
12
73
1.75
0.86
2.4
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
292
0.66
0.86
1.9
1.7
g/l
1.6
1.6
0.00
12
150
(3035637) Corticotropin [Mass/volume] in Plasma
6
32
1.94
0.83
2.3
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
15
100
1.61
0.79
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
23
2.24
0.77
1.6
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
9
55
1.71
0.76
6.9
7.1
ng/l
4937.9
1307.7
—
9
44
(1761868) Lipid panel - Serum or Plasma
17
118
1.55
0.76
2.3
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
60
1.75
0.75
5.1
7.2
%
92.8
90.4
—
10
60
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
118
0.55
0.75
2.1
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
39
1.86
0.74
1.4
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
37
302
1.40
0.74
4.5
3.1
mmol/mol
35.1
35.7
0.14
37
278
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
91
0.52
0.72
1.0
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
5
28
1.83
0.67
11.4
2.6
mmol/l
1.3
1.2
—
5
23
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
44
1.64
0.67
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30
240
1.39
0.66
4.2
4.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
21
0.00
0.61
0.0
5.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
21
0.00
0.61
0.0
1.9
—
2.5
—
0
6
(21494815) CD4 cells/100 lymphocytes in Specimen
0
22
0.00
0.60
0.0
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
178
0.68
0.57
1.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
19
242
0.72
0.56
3.2
8.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
12
83
1.52
0.55
3.2
2.8
ng/l
164.6
19.7
—
7
32
(3009508) Creatinine [Moles/volume] in Urine
19
145
1.40
0.54
7.6
4.8
mmol/l
8.1
8.4
0.11
19
134
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12
164
0.68
0.52
6.7
4.8
u/l
37.2
33.9
0.11
12
155
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
147
1.38
0.50
11.3
11.2
mmol/l
-0.7
1.1
0.57
13
96
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
115
0.66
0.50
1.6
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
61
653
0.74
0.49
12.6
10.9
mg/l
18.0
23.7
0.81
48
435
(3037467) Urinalysis macro (dipstick) panel - Urine
44
387
1.29
0.48
7.6
4.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
339
0.77
0.46
2.0
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
20
161
1.32
0.41
3.3
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
8
60
1.36
0.41
5.1
4.7
e9/l
64.3
59.5
—
8
45
(42529406) Shigella sp [Presence] in Stool by Culture
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
294.6
—
0
12
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
36
404
0.80
0.39
8.5
10.7
e9/l
0.0
0.0
0.00
31
308
(3026493) Urate [Moles/volume] in Serum or Plasma
9
70
1.32
0.38
22.7
5.1
umol/l
279.4
299.9
—
9
65
(3018095) Leukocytes [#/volume] in Urine
28
239
1.25
0.37
5.8
6.0
e6/l
20.9
41.3
0.58
20
168
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
229
0.78
0.37
1.6
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
27
230
1.25
0.37
1.6
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
42
1.46
0.36
1.0
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
91
1.37
0.35
3.7
2.5
u/l
916.0
4264.8
—
5
31
(3014576) Chloride [Moles/volume] in Serum or Plasma
7
52
1.37
0.32
5.0
13.7
mmol/l
105.4
106.2
—
7
52
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
139
0.76
0.30
1.9
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
63
659
0.81
0.29
8.4
13.9
%
39.0
39.1
0.05
53
585
(3021447) Carbon dioxide [Partial pressure] in Venous blood
11
137
0.77
0.27
9.9
11.2
kpa
6.0
5.8
0.47
11
132
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
158
0.79
0.27
2.9
3.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
9
74
1.24
0.26
1.6
1.2
nmol/l
14.4
19.3
—
9
59
(3004789) Transferrin [Mass/volume] in Serum or Plasma
9
76
1.20
0.25
4.6
3.6
g/l
2.6
2.7
—
9
71
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
81
0.72
0.25
2.0
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
11
88
1.28
0.23
5.7
7.4
%
1.6
1.2
0.67
11
83
(3029937) Albumin [Presence] in Urine by Test strip
17
145
1.21
0.22
4.9
4.4
estimate
0.0
0.0
—
7
57
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
13
154
0.81
0.21
10.9
13.5
mmol/l
24.1
24.7
0.69
13
154
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
1.1
—
0
10
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
9.3
—
10.7
—
0
12
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(44813793)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(4198724)
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
43.6
—
0
14
(3028300) Cannabinoids [Presence] in Urine
11
90
1.25
0.20
1.3
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
33
302
1.15
0.20
5.5
9.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.8
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
52
1.16
0.19
6.8
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
23
207
1.15
0.17
2.1
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
207
1.15
0.17
1.8
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
72
1.12
0.16
1.3
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
129
0.83
0.16
1.2
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
208
1.14
0.15
9.8
5.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
82
1.11
0.15
1.2
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
11
128
0.84
0.15
10.5
10.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
9
108
0.81
0.14
2.1
1.8
mmol/l
1.5
1.2
—
9
101
(3009261) Glucose [Presence] in Urine by Test strip
29
269
1.12
0.13
4.3
4.2
estimate
0.0
0.0
—
7
56
(3044889) 12 lead EKG panel
22
238
0.89
0.12
2.4
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
27
251
1.11
0.11
5.4
3.9
nmol/l
73.9
68.4
0.56
27
229
(3018418) pH of Serum or Plasma
10
114
0.86
0.10
7.0
3.8
ph
7.4
7.4
—
5
21
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5
46
1.09
0.10
2.8
1.5
mmol/l
2.4
2.4
—
5
35
(3028707) Methadone [Presence] in Urine by Screen method
5
46
1.09
0.10
1.4
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
47
1.07
0.09
1.8
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
63
0.78
0.08
2.2
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
104
0.85
0.06
3.9
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
15
138
1.10
0.06
5.5
3.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
90
1.12
0.05
1.2
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
90
1.12
0.05
1.2
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
69
698
0.92
0.04
3.6
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
26
269
0.95
0.03
5.8
5.8
estimate
0.0
0.0
—
7
56
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
188
0.94
0.03
5.3
3.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
221
1.05
0.02
2.3
2.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
30
291
1.04
0.02
3.4
4.7
u/l
35.4
25.3
0.90
30
280
(36304419) Bacteria [Presence] in Urine
19
183
1.05
0.01
5.4
4.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
12
114
1.06
0.00
2.3
2.6
u/l
55.8
62.5
0.18
12
101
(40768804) Tissue Pathology biopsy report
16
154
1.05
0.00
1.4
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
12
123
0.97
0.00
2.1
1.4
pmol/l
94.3
94.8
—
7
65
(3035350) Ketones [Presence] in Urine by Test strip
27
269
1.00
0.00
4.6
4.1
estimate
0.0
0.0
—
5
56
(3019832) Treponema pallidum Ab [Presence] in Serum
15
152
0.98
0.00
1.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
37
371
0.99
0.00
5.7
6.8
ml/min/173m2
109.5
112.8
0.28
30
238
(40761511) CBC panel - Blood by Automated count
65
647
1.01
0.00
11.6
8.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
139
1.01
0.00
12.5
9.2
mmol/l
24.0
23.9
0.04
14
139
(3022313) Gas panel - Capillary blood
14
138
1.01
0.00
13.1
10.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
107
1.03
0.00
2.1
3.6
—
—
—
0
0
(3015736) pH of Urine
21
211
0.99
0.00
3.0
3.8
—
—
—
0
0
(4268621)
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
9
0.00
0.00
0.0
1.1
—
166.3
—
0
9
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.1
—
0
5
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
97.3
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
68
0.87
0.00
1.5
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
69
0.86
0.00
1.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
2.4
1.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
85
0.93
0.00
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
55
0.90
0.00
1.0
2.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
7.2
—
333.2
—
0
5
(3043409) Potassium [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
3.0
—
4.0
—
0
5
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
38.7
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
90
1.00
0.00
1.2
2.1
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
22.8
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
4.0
—
4.5
—
0
7
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
30.4
—
0
5
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
21.6
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FET_NEWB_OTH_COMPLICATIO_LABOUR_DELIV – Fetus and newborn affected by other complications of labour and delivery
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data